The Weekly Scale: May 10th, 2021

This week at MarketScale, we’ll launch some of our newest contributor podcasts, explore the conversations powering industrialized construction, and analyze the QSR industry’s growing need for personalized experiences.

It’s the start of a new week, and it’s time to scale up.

Why is southern California becoming the hub of green transportation?

On the latest episode of Careers on the Move, a Cargomatic podcast, host Shelby Skrhak spoke to a front-line expert about getting goods from A to B as greenly and efficiently as possible.

There’s no denying that the environmental movement has grown exponentially in the last decade. But, unlike other movements, sustainability isn’t something we can easily measure or notice a palpable change with.

On the first episode of Breaking New Ground, host Joel Pennington brings together two leaders driving radical change in the built environment today, Arol Wolford and Charlie Cichetti

What is the role of 5G in the future of retail?

This week on Retail Refined, VP of Retail, Restaurants and Hospitality for AT&T Michael Colaneri speaks about how 5G will enable retailers to deploy experiential content, such as “magic mirrors” that empower consumers to try on clothes without being physically present.

Will 5G change the ability for paramedics to communicate with doctors in the hospital?

This week on In The Cloud, Host Hilary Kennedy talked with Dr. Arslan Usman, a telemedicine and wireless connectivity expert to find out.

On this week’s MarketScale Roundtable, we’re exploring how QSR is personalizing various aspects of its operations, technologies and experience for the end-user.

The panel will include:

Brandon Powers, KPS

Kevin Bessy, Humdinner

Bill Stavrou, Foodhaul

Margine Biswas, Archiphy

Make sure to follow along for future roundtables. We will also be checking out what we can expect for a summer full of travel on the hospitality roundtable on the 17th.

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More